What Happened?
South San Francisco, CA-based Antiva Biosciences Appointed Karl Hostetler as Executive Director
About the Company
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego and builds on his anti-viral expertise as co-founder of Triangle Pharmaceuticals and Chimerix. Antiva`s chemistry platform has yielded over two hundred proprietary pro-drug compounds that are designed to enhance the therapeutic index of known, potent antivirals.
About the Person
Karl Hostetler is Executive Director at . Previously, Karl held various senior HR leadership roles in the industry.
Info Source
News
Short Profile